-
Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.（欧文）（査読付）,Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):472-8.
Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.
-
Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. .（欧文）（査読付）,Int J Radiat Oncol Biol Phys 2009 Nov 1;72(3):828-33.
Nomiya T, Tsuji H, Hirasawa N, Kato H, Kamada T, Mizoe J, Kishi H, Kamura K, Wada H, Nemoto K, Tsujii H.
-
Metastatic angiosarcoma of the lung with alveolar hemorrhage.（欧文）（査読付）,Jpn J Radiol. 2009 Nov;27(9):381-4. doi: 10.1007/s11604-009-0352-1.
Saitoh J, Sakurai H, Suzuki Y, Katoh H, Takahashi T, Nakano T.
-
Clinical application of the Fricke-glucomannan gel dosimeter for high-dose-rate (192)Ir brachytherapy.（欧文）（査読付）,Phys Med Biol. 2008 Jul 21;53(14):3985-93. doi: 10.1088/0031-9155/53/14/016.
Noda S, Suzuki Y, Hoshino Y, Furukawa S, Katoh H, Kurotaki K, Nakano T.
-
Clinical Results of Carbon Ion Radiotherapy at NIRS.,J Radiat Res 2007 48:Suppl A:A1-A13.
Tsujii H, Mizoe J, Kamada T, Baba M, Tsuji H, Kato H, Kato S, Yamada S, Yasuda S, Ohno T, Yanagi T, Imai R, Kagei K, Kato H, Hara R, Hasegawa A, Nakajima M, Sugane N, Tamaki N, Takagi R, Kandatsu S, Yoshikawa K, Kishimoto R, Miyamoto T.
-
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.（欧文）（査読付）,Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):364-70.
Akimoto T, Katoh H, Kitamoto Y, Tamaki T, Harada K, Shirai K, Nakano T.
-
Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization.（欧文）（査読付）,Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1360-6.
Akimoto T, Katoh H, Kitamoto Y, Shirai K, Shioya M, Nakano T.
-
FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.（欧文）（査読付）,Gynecol Oncol. 2006 Mar;100(3):601-7.
Sakurai H, Suzuki Y, Nonaka T, Ishikawa H, Shioya M, Kiyohara H, Katoh H, Nakayama Y, Hasegawa M, Nakano T.
-
Acute toxicity and preliminary clinical outcomes of concurrent radiation therapy and weekly docetaxel and daily cisplatin for head and neck cancer.（欧文）（査読付）,Jpn J Clin Oncol. 2005 Nov;35(11):639-44.
Kitamoto Y, Akimoto T, Ishikawa H, Nonaka T, Katoh H, Nakano T, Ninomiya H, Chikamatsu K, Furuya N.
-
Protective effect of urinary trypsin inhibitor on the development of radiation-induced lung fibrosis in mice.（欧文）（査読付）（学位論文）,J Radiat Res. 2010;51(3):325-32.
Katoh H, Ishikawa H, Hasegawa M, Yoshida Y, Suzuki Y, Ohno T, Takahashi T, Nakano T.
-
The role of radiotherapy for thymic carcinoma.,Jpn J Clin Oncol 2004 Dec;34(12):722-6.
Nonaka T, Tamaki Y, Higuchi K, Katoh H, Nakahashi M, Horikoshi H, Takahashi K, Minato K, Sugihara S, Kojima M.
-
新しい治療：重粒子線治療の意義/位置づけ（和文）,泌尿器外科：23（８）1057-1059,2010.
石川仁，辻比呂志，加藤弘之，中野隆史，伊藤一人，鈴木和浩, 島崎淳，鎌田正
-
マイクロセレクトロンによる治療（和文）,PET Journal 11：29-31,2010
大野達也，加藤弘之，野田真永
-
Skin-promontory distanceは子宮頸癌外部骨盤照射において前後左右4門照射法により小腸線量がよく軽減される症例を検出するための指標となる（和文） ,臨床放射線 55(7), 904-908, 2010-07
尾池貴洋、大野達也、野田真永、若月優、加藤弘之、齋藤淳一、吉本由哉、小此木範之、水上達治、鈴木義行、高橋健夫、中野隆史
-
【ここまで来た重粒子線治療 現状と将来展望】 重粒子線治療研究の過去、現在、未来 放医研における重粒子線治療の臨床成果（和文）,放射線科学50(7):5-19, 2007.
辻井博彦、鎌田正、溝江純悦、馬場雅行、辻比呂志、加藤博敏、加藤真吾、山田滋、安田茂雄、柳剛、今井礼子、加藤弘之、原竜介、山本直敬、須金紀雄、長谷川安都佐、高木亮、中嶋美緒、田巻倫明、清原浩樹、 今田浩史、野宮琢磨、別所央城、恩田健志、神立進、吉川京燦、岸本理和、江澤英史．
-
【前立腺がん放射線療法の進歩】 放射線治療の合併症・QOL評価・改善のための工夫 前立腺癌に対する外照射併用高線量率組織内照射後の急性反応 Geometrical optimizationとanatomy based inverse optimizationの比較（和文） ,泌尿器外科19(8):975-979, 2006.
秋元哲夫, 加藤弘之, 白井克幸, 田巻倫明, 原田耕作, 山本巧, 伊藤一人, 鈴木和浩, 中野隆史
-
婦人科悪性腫瘍の臨床におけるPETの有効性とその限界 子宮頸癌の臨床におけるFDG-PETの有効性とその限界（和文）,日本婦人科腫瘍学会雑誌24(1):35-40, 2006
桜井英幸、鈴木義行、野中哲生、塩谷真里子、清原浩樹、加藤弘之、秋元哲夫、中野隆史
-
16chMDCTを使ったMPR像と核医学画像のfusionについて（和文）,群馬県核医学研究会会誌18(2):51-53, 2004.
原口万須美, 堀越浩幸, 加藤弘之, 野中哲生, 樋口啓子, 玉木義雄
-
Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.（欧文）（査読付） ,Int J Urol. 2014 Apr;21(4):370-5. doi: 10.1111/iju.12294."
Katoh H, Tsuji H, Ishikawa H, Kamada T, Wakatsuki M, Hirasawa N, Suzuki H, Akakura K, Nakano T, Shimazaki J, Tsujii H.
-
Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer（欧文）（査読付）,J Radiat Res. 2017 Jan;58(2):260-6. doi: 10.1093/jrr/rrv122.
Maruyama K, Tsuji H, Nomiya T, Katoh H, Ishikawa H, Kamada T, Wakatsuki M, Akakura K, Shimazaki J, Aoyama H, Tsujii H
-
Initial Results of Hypofractionated Carbon Ion Radiotherapy for Cholangiocarcinoma.（欧文）（査読付）,Anticancer Res. 2016 Jun;36(6):2955-60.Anticancer Res. 2016 Jun;36(6):2955-60.D40:F50
Abe T, Shibuya K, Koyama Y, Okamoto M, Kiyohara H, Katoh H, Shimada H, Kuwano H, Ohno T, Nakano T.
-
Changes in Rectal Dose Due to Alterations in Beam Angles for Setup Uncertainty and Range Uncertainty in Carbon-Ion Radiotherapy for Prostate Cancer.（欧文）（査読付）,PLoS One. 2016 Apr 20;11(4):e0153894. doi: 10.1371/journal.pone.0153894.
Kubota Y, Kawamura H, Sakai M, Tsumuraya R, Tashiro M, Yusa K, Kubo N, Sato H, Kawahara M, Katoh H, Kanai T, Ohno T, Nakano T.
-
Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life.（欧文）（査読付）,Anticancer Res. 2015 Oct;35(10):5559-66.
Ishikawa H, Katoh H, Kaminuma T, Kawamura H, Ito K, Matsui H, Hirato J, Shimizu N, Takezawa Y, Tsuji H, Suzuki K, Ohno T, Nakano T; Group for Genitourinary Tumors at Gunma Heavy Ion Medical Center..
-
Clinical outcomes of helical tomotherapy for super-elderly patients with localized and locally advanced prostate cancer: comparison with patients under 80 years of age.（欧文）（査読付）,J Radiat Res. 2015 Nov;56(6):889-96. doi: 10.1093/jrr/rrv040.
Okonogi N, Katoh H, Kawamura H, Tamaki T, Kaminuma T, Murata K, Ohkubo Y, Takakusagi Y, Onishi M, Sekihara T, Okazaki A, Nakano T.
-
Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma.（欧文）（査読付）,Radiat Oncol. 2012 Jul 23;7:112. doi: 10.1186/1748-717X-7-112.
Kawamura H, Ebara T, Katoh H, Tamaki T, Ishikawa H, Sakurai H, Nakano T.
-
Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.（欧文）（査読付）,Brachytherapy. 2012 Mar-Apr;11(2):130-6. doi: 10.1016/j.brachy.2011.05.008.
Tamaki T, Ishikawa H, Takahashi T, Tamaki Y, Kitamoto Y, Okamoto M, Noda SE, Katoh H, Shirai K, Sakurai H, Nakano T.
-
Radiation-induced ICAM-1 expression via TGF-β1 pathway on human umbilical vein endothelial cells; comparison between X-ray and carbon-ion beam irradiation.（欧文）（査読付）,J Radiat Res. 2011;52(3):287-92.
Kiyohara H, Ishizaki Y, Suzuki Y, Katoh H, Hamada N, Ohno T, Takahashi T, Kobayashi Y, Nakano T.
-
Intracavitary combined with CT-guided interstitial brachytherapy for locally advanced uterine cervical cancer: introduction of the technique and a case presentation.（欧文）（査読付）,J Radiat Res. 2011;52(1):54-8.
Wakatsuki M, Ohno T, Yoshida D, Noda SE, Saitoh J, Shibuya K, Katoh H, Suzuki Y, Takahashi T, Nakano T.
-
Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients.（欧文）（査読付）,Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1002-7. doi: 10.1016/j.ijrobp.
Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, Nonaka T, Ishikawa H, Katoh H, Takahashi T, Nakano T.
-
Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up.（欧文）（査読付）,Cancers (Basel). 2011 Oct 26;3(4):4046-60. doi: 10.3390/cancers3044046.
Ohno T, Kanai T, Yamada S, Yusa K, Tashiro M, Shimada H, Torikai K, Yoshida Y, Kitada Y, Katoh H, Ishii T, Nakano T.
-
The benefit of small bowel and pelvic bone sparing in excluding common iliac lymph node region from conventional radiation fields in patients with uterine cervical cancer: a dosimetric study.（欧文）（査読付）,J Radiat Res. 2010;51(6):715-21.
Oike T, Ohno T, Wakatsuki M, Noda SE, Saitoh J, Mizukami T, Yoshimoto Y, Okonogi N, Katoh H, Shibuya K, Suzuki Y, Ishikawa H, Ebara T, Takahashi T, Nakano T.
